They found that people who had been prescribed these drugs more frequently, or who took multiple types, had a higher risk of ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...

A large case-control study suggests that calcium channel blockers are the only antihypertensives that reduce the risk for Parkinson disease ... of antihypertensive drugs: angiotensin-converting ...

The 194 people with Parkinson’s disease involved ... Researchers identify 21 existing drugs that could treat coronavirus Check out the Valentine Week List 2025, along with the Valentine ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds By India Edwards HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could ...

GLP-1 drugs like Ozempic do not slow Parkinson's disease, study finds The trial showed no benefit in symptoms or brain scans Experts say more research is needed before using these drugs for brain ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found that a drug in the same class ...